Skip to main content
. 2017 May 22;108(5):886–896. doi: 10.1111/cas.13210

Figure 2.

Figure 2

Clinical significance of microRNA (miR)‐135a‐3p in patients with ovarian cancer, other gynecologic diseases, and normal ovary. (a) Level of miR‐135a‐3p in serum samples. Closed, open, and shaded columns indicate the expression index of miR‐135a‐3p in patients with ovarian cancer (OVCA), benign ovarian tumor (OVT), or normal ovary (Control), respectively. (b) Expression of miR‐135a‐3p in tissue samples. Closed and open columns indicate the expression index of miR‐135a‐3p in patients with ovarian cancer (OVCA) or normal ovary (Normal), respectively. (c) Level of miR‐135a‐3p in peritoneal fluid samples. Closed and open columns indicate the expression index of miR‐135a‐3p in patients with ovarian cancer (OVCA) or benign ovarian tumor (OVT), respectively. All data indicate mean ± standard error. Bar indicates standard error. *P < 0.05. n, number of patients.